COVID-19 (SARS-CoV-2) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used for qualitative detection of the ORF1ab and N genes of novel coronavirus (SARS-CoV-2) in pharyngeal swabs and alveolar lavage samples in suspected pneumonia cases with novel coronavirus infection, in patients with suspected clusters of novel coronavirus infection, and other patients requiring diagnosis or differential diagnosis of novel coronavirus infection.
For in vitro diagnostic use only. For professional use only.
By applying Real-time fluorescence quantitative RT-PCR technology on the fluorescence quantitative PCR instrument, this test utilizes the novel coronavirus (SARS-CoV-2) ORF 1ab and the specific conserved sequence of coding nucleocapsid protein N gene as the target regions which are designed for the conserved sequence of the double-target genes, to achieve detection of sample RNA through fluorescent signal changes. The PCR detection system uses the positive internal control, which monitors the presence of PCR inhibitors in test specimens by detecting whether the internal control signal is normal, to avoid a false negative result.
Minimum order: 50 kits x 24 tests.